We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

214 hedge funds and large institutions have $1.82B invested in Beam Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $7.11M

18% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 62

8.14% more ownership

Funds ownership: 86.14% → 94.28% (+8.1%)

3% less funds holding

Funds holding: 221 → 214 (-7)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

22% less capital invested

Capital invested by funds: $2.32B → $1.82B (-$504M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
214
Holders Change
-7
Holders Change %
-3.17%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
36
Increased
73
Reduced
62
Closed
41
Calls
$16.6M
Puts
$7.11M
Net Calls
+$9.45M
Net Calls Change
+$24.8M

Top Buyers

1
AVM
Arch Venture Management
Illinois
+$134M
2
FCM
Farallon Capital Management
California
+$83.5M
3
First Trust Advisors
First Trust Advisors
Illinois
+$36.4M
4
BlackRock
BlackRock
New York
+$22.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$19.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$81.5M
2
DGM
Darwin Global Management
Jersey
-$70M
3
AIM
ARK Investment Management
Florida
-$13.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$12M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
76
Cresset Asset Management
Illinois
$1.09M +$885K +36,036 +340%
VOYA Investment Management
77
VOYA Investment Management
Georgia
$1.03M +$185K +7,543 +21%
MIM
78
MetLife Investment Management
New Jersey
$1.02M +$134K +5,450 +14%
Wellington Management Group
79
Wellington Management Group
Massachusetts
$1.01M +$249K +10,155 +31%
Two Sigma Advisers
80
Two Sigma Advisers
New York
$1M -$2.59M -105,400 -71%
GITFIT
81
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)
Poland
$984K +$1.03M +42,000 New
CF
82
Corebridge Financial
Texas
$964K +$1.01M +41,134 New
Jacobs Levy Equity Management
83
Jacobs Levy Equity Management
New Jersey
$962K +$1.01M +41,076 New
Hudson Bay Capital Management
84
Hudson Bay Capital Management
Connecticut
$879K +$921K +37,500 New
Janus Henderson Group
85
Janus Henderson Group
United Kingdom
$867K +$241K +9,815 +36%
ECU
86
Eisler Capital (US)
New York
$805K +$844K +34,378 New
XT
87
XTX Topco
Cayman Islands
$745K +$781K +31,810 New
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
$739K +$13.1K +533 +2%
PA
89
Profund Advisors
Maryland
$723K -$191K -7,768 -20%
SSA
90
Schonfeld Strategic Advisors
New York
$715K -$447K -18,181 -37%
Ensign Peak Advisors
91
Ensign Peak Advisors
Utah
$682K – – –
TRCT
92
Tower Research Capital (TRC)
New York
$665K +$548K +22,319 +369%
LPL Financial
93
LPL Financial
California
$619K +$62.3K +2,536 +11%
GCM
94
Graham Capital Management
Connecticut
$572K +$599K +24,399 New
State Board of Administration of Florida Retirement System
95
State Board of Administration of Florida Retirement System
Florida
$559K +$97K +3,950 +20%
Schroder Investment Management Group
96
Schroder Investment Management Group
United Kingdom
$551K – – –
EAM
97
Erste Asset Management
Austria
$520K – – –
CC
98
Corton Capital
Ontario, Canada
$515K +$539K +21,964 New
QCM
99
QRG Capital Management
Illinois
$497K -$44.4K -1,806 -8%
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$489K -$5.43K -221 -1%
2 3
4
5 6

BEAM Hedge Fund Activity: Q2 2024 in Review

214 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2024, worth a combined $1.82B — down 22% from $2.32B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of BEAM and 36 opened new positions — a net loss of 5 holders — while 62 trimmed existing stakes and 73 added.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $134M. The largest seller was Morgan Stanley, cutting an estimated $81.5M.

  • 214 institutional investors held Beam Therapeutics (BEAM) as of Q2 2024, down from 221 in Q1 2024.
  • Funds reported $1.82B of Beam Therapeutics stock for Q2 2024, down 22% quarter-over-quarter.
  • 36 funds opened new Beam Therapeutics positions in Q2 2024 and 41 closed out, a net change of -5 holders.
  • The largest Beam Therapeutics buyer in Q2 2024 was Arch Venture Management, an estimated $134M added.
  • The largest Beam Therapeutics seller in Q2 2024 was Morgan Stanley, an estimated $81.5M sold.

Based on aggregated 13F filings for Q2 2024.